Total Payments
$327.47
2023 Payments
$20.18
Companies
7
Transactions
17
Medicare Patients
1,783
Medicare Billing
$81,896
Payment Breakdown by Category
Food & Beverage$327.47 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $327.47 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $143.34 | 9 | $0 (2021) |
| Allergan, Inc. | $90.58 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $23.56 | 2 | $0 (2017) |
| PFIZER INC. | $20.18 | 1 | $0 (2023) |
| VBI Vaccines (Delaware) Inc. | $18.61 | 1 | $0 (2022) |
| Nabriva Therapeutics, plc | $17.59 | 1 | $0 (2021) |
| Lilly USA, LLC | $13.61 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.18 | 1 | PFIZER INC. ($20.18) |
| 2022 | $38.65 | 2 | Allergan, Inc. ($20.04) |
| 2021 | $75.61 | 5 | Genentech USA, Inc. ($44.41) |
| 2020 | $69.83 | 4 | Genentech USA, Inc. ($69.83) |
| 2019 | $99.64 | 3 | Allergan Inc. ($70.54) |
| 2017 | $23.56 | 2 | Merck Sharp & Dohme Corporation ($23.56) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/23/2022 | VBI Vaccines (Delaware) Inc. | PreHevbrio (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: VACCINE | ||||||
| 02/24/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $20.04 | General |
| 11/11/2021 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Antibiotic | ||||||
| 01/31/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Virology & Specialty Care | ||||||
| 01/21/2021 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Neuroscience | ||||||
| 01/19/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Virology & Specialty Care | ||||||
| 01/12/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Virology & Specialty Care | ||||||
| 12/11/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Virology & Specialty Care | ||||||
| 11/10/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Virology & Specialty Care | ||||||
| 03/02/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Virology & Specialty Care | ||||||
| 02/18/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Virology & Specialty Care | ||||||
| 10/28/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Virology & Specialty Care | ||||||
| 09/12/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $70.54 | General |
| 03/21/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Virology & Specialty Care | ||||||
| 05/16/2017 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/16/2017 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 269 | 285 | $40,070 | $16,521 |
| 2022 | 10 | 356 | 373 | $43,594 | $19,448 |
| 2021 | 7 | 538 | 559 | $50,185 | $22,948 |
| 2020 | 8 | 620 | 647 | $53,096 | $22,979 |
Total Patients
1,783
Total Services
1,864
Medicare Billing
$81,896
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 96 | $13,140 | $5,713 | 43.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $7,500 | $3,688 | 49.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $11,105 | $3,626 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 27 | $5,025 | $1,863 | 37.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 29 | 29 | $2,030 | $1,004 | 49.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 21 | 21 | $630.00 | $340.62 | 54.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 12 | $420.00 | $194.40 | 46.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $220.00 | $92.40 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $12,720 | $5,502 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 47 | $8,145 | $4,348 | 53.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $7,325 | $3,146 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 61 | $6,960 | $2,908 | 41.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 68 | 70 | $4,900 | $2,448 | 50.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 27 | 28 | $840.00 | $456.27 | 54.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 25 | 25 | $1,000 | $424.96 | 42.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $984.00 | $126.63 | 12.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 25 | $500.00 | $55.36 | 11.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 11 | 11 | $220.00 | $32.46 | 14.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 187 | 195 | $13,650 | $6,889 | 50.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 96 | 96 | $14,900 | $5,928 | 39.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 95 | $10,020 | $5,018 | 50.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 125 | 128 | $5,120 | $2,059 | 40.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,600 | $1,567 | 43.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 17 | $2,635 | $1,457 | 55.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 13 | $260.00 | $29.25 | 11.3% |
About Dr. Anna Holzer, MD
Dr. Anna Holzer, MD is a Family Medicine healthcare provider based in Altoona, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1457664799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Holzer, MD has received a total of $327.47 in payments from pharmaceutical and medical device companies, with $20.18 received in 2023. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($327.47).
As a Medicare-enrolled provider, Holzer has provided services to 1,783 Medicare beneficiaries, totaling 1,864 services with total Medicare billing of $81,896. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Altoona, IA
- Active Since 07/15/2010
- Last Updated 12/21/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1457664799
Products in Payments
- Xofluza (Drug) $143.34
- SIVEXTRO (Drug) $23.56
- PAXLOVID (Drug) $20.18
- PreHevbrio (Drug) $18.61
- Xenleta (Drug) $17.59
- REYVOW (Drug) $13.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Altoona
David Lemchak, Do, DO
Family Medicine — Payments: $8,660
Family Medicine $8,660
Mr. Elias Rifkah, Md, MD
Family Medicine — Payments: $8,131
Family Medicine $8,131
Amanda Cattoi-Seifert, Md, MD
Family Medicine — Payments: $6,899
Family Medicine $6,899
Jeffrey Armstrong, Md, MD
Family Medicine — Payments: $2,402
Family Medicine $2,402
Dr. John Reinhardt, D.o, D.O
Family Medicine — Payments: $2,067
Family Medicine $2,067
Sarah Reinhardt, D.o, D.O
Family Medicine — Payments: $1,812
Family Medicine $1,812